ArticleSignal transduction and targeted therapy2026
TCR-mimic bispecific nanobody-based T cell engager targeting intracellular tumor antigens for cancer immunotherapy.
Ziqiang Ding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.